A Study to Find the Best Dose of BI 1387446 Alone or in Combination With Ezabenlimab (BI 754091) in Patients With Different Types of Advanced or Metastatic Cancer (Solid Tumors)
Clinical trial NCT04147234 · COMPLETED
Trial details
- NCT number
- NCT04147234
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-08-03
- Primary completion
- 2022-11-15
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.